Evaluation of second-line treatment options in non-small cell lung cancer - Introduction

被引：1
|
作者：
Scagliotti, GV [1 ]
机构：
[1] Univ Turin, Dept Clin & Biol Sci, Turin, Italy
来源：
SEMINARS IN ONCOLOGY | 2006年 / 33卷 / 01期
关键词：
D O I：
10.1053/j.seminoncol.2005.12.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 50 条
  • [1] The safety of second-line treatment options for non-small cell lung cancer
    Rossi, Antonio
    Maione, Paolo
    Santabarbara, Giuseppe
    Sacco, Paola Claudia
    Casaluce, Francesca
    Sgambato, Assunta
    Barzelloni, Maria Luisa
    Palazzolo, Giovanni
    Gridelli, Cesare
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 471 - 479
  • [2] Second-line treatment options in advanced non-small cell lung cancer
    de Marinis, Filippo
    Ricciardi, Serena
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S258 - S271
  • [3] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer
    Scagliotti, G
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2855 - 2866
  • [4] Second-line treatment options in advanced non-small cell lung cancer: Current status
    Cullen, M
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S3 - S8
  • [5] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [6] Single agents in the second-line treatment of non-small cell lung cancer
    Belani, CP
    [J]. SEMINARS IN ONCOLOGY, 1998, 25 (03) : 10 - 14
  • [7] Geographic variation in the second-line treatment of non-small cell lung cancer
    Edelman, MJ
    Sekine, I
    Tamura, T
    Saijo, N
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S39 - S44
  • [8] Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer
    Pesek, M
    Holá, V
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 155 - 160
  • [9] Racotumomab in Non-Small Cell Lung Cancer as Maintenance and Second-Line Treatment
    Caceres-Lavernia, Haslen H.
    Neninger-Vinageras, Elia
    Varona-Rodriguez, Leslie M.
    Olivares-Romero, Yoli A.
    Sanchez-Rojas, Irlis
    Mazorra-Herrera, Zaima
    Basanta-Bergolla, Denenke
    Duvergel-Calderin, Dayanis
    Torres-Cuevas, Boris L.
    del Castillo-Carrillo, Concepcion
    [J]. MEDICC REVIEW, 2021, 23 (3-4) : 21 - 28
  • [10] Future directions in the second-line treatment of non-small cell lung cancer
    Rosell, R
    Cecere, F
    Cognetti, F
    Cuello, M
    Sanchez, JM
    Taron, M
    Reguart, N
    Jablons, D
    [J]. SEMINARS IN ONCOLOGY, 2006, 33 (01) : S45 - S51
12345